0001699382 2026-03-05 2026-03-05 0001699382 1 2026-03-05 2026-03-05 iso4217:USD pure shares S-8 S-8 EX-FILING FEES 0001699382 PMV Pharmaceuticals, Inc. N/A false S-8 PMV Pharmaceuticals, Inc. Equity Common Stock, $0.00001 par value per share, reserved for issuance pursuant to the 2020 Equity Incentive Plan true 2666470 1.55 4133028.50 0.0001381 570.77 4133028.50 570.77 0.00 570.77 (1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall cover any additional shares of the Registrant's common stock that become issuable under the 2020 Equity Incentive Plan (the "2020 Plan") by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected without receipt of consideration that increases the number of the Registrant's outstanding shares of common stock. (2) Represents an automatic annual increase on January 1, 2026 equal to 5% of the total number of shares of the Registrant's common stock outstanding on December 31 of the preceding year, which annual increase is provided for in the 2020 Plan. (3) Estimated in accordance with Rule 457(c) and 457(h) solely for the purpose of calculating the registration fee on the basis of $1.55 per share, which represents the average of the high and low prices of the Registrant's common stock as reported on the Nasdaq Global Select Market on March 4, 2026.